$VIZS Vizstar, Inc. Announces Kimberly Parry and

New Post Public Reply Private Reply Replies (0) Message Board
jstops

[b]$VIZS[/b] Vizstar, Inc. Announces Kimberly Parry and Jean-Michel Cousteau to Appear Together on Money TV


SAN CLEMENTE, Calif., [b][color=blue]May 15, 2013[/color][/b] /PRNewswire/ -- Vizstar, Inc. (pinksheets:VIZS) has announced subsidiary kimberlyparry.com CEO Kimberly Parry will appear with Jean-Michel Cousteau in an upcoming episode of Money TV with Don Baillargeon.


For more than four decades, Jean-Michel Cousteau, the son of famed oceanographer Jacques Cousteau, has dedicated himself and his vast experience to communicate to people of all nations and generations, his love and concern for our water planet. Cousteau has endorsed the Kimberly Parry product line because of its purity.


"What an iconic name to be associated with," said Ms. Parry. "We are so excited to be collaborating with them!"


Kimberly Parry Organics creates luxurious spa products that harness the power of botanicals and aromatherapy to provide gentle, yet effective results. Formulated to the highest USDA certification standards, their spa products are USDA certified organic and made fresh to order in their manufacturing facility in San Clemente, California.


Kimberly Parry Organics offers a full range of products including organic skin care, organic bath and body products, organic mom and baby care and luxurious organic spa treatments for destination, resort and day spas.


For more information, please visit www.vizstar.net  www.kimberlyparry.com


About Vizstar, Inc.


Vizstar, Inc. is an aggregator of companies and products in the organic cosmetic, wellness and skincare space. Vizstar, Inc. is focused on companies that are USDA Certified Organic possessing both patents and product distribution.


Contact Information: Kimberly Parry Corporation (949) 481-8212

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Hims & Hers Health Faces Revenue Challenges and Legal Issues

Updated Category News Views 246

Hims & Hers Revenue Challenges Amid Stock Decline In recent trading sessions, Hims & Hers Health reported notable stock fluctuations as the company unveiled a decline in revenue per customer linked to its customization of GLP-1 medications for weight loss. This announcement caused an almost 11% drop in the stock price. Impacts of Collaboration Termination This steep...

Continue Reading
Entrée Resources Reports Solid Results for Q3 2025

Updated Category News Views 166

Entrée Resources Ltd. Overview Entrée Resources Ltd. (TSX: ETG; OTCQB: ERLFF), a reputable Canadian mining company focused on the Oyu Tolgoi project, has announced its interim financial results for the third quarter of 2025. This announcement sheds light on its ongoing operations and future plans, emphasizing the company's significant role in one of the world's largest...

Continue Reading
Bucket List Wine Dinners Beckon to Los Angeles

Updated Category News Views 10

Sipping on the Extraordinary: LA Wine Soiree When was the last time you had a glass of wine that truly feels like you've unlocked a treasure chest? That's what LearnAboutWine.com is going for with their bucket list wine dinners in Los Angeles. Imagine tasting some of the world's most coveted bottles, all served with a level of polish that screams high-end dining. Led by...

Continue Reading
BioLife Solutions Enhances Growth Potential with $73 Million Sale

Updated Category News Views 68

BioLife Solutions Announces $73 Million Sale of SciSafe In a significant move aimed at reinforcing its strategic direction, BioLife Solutions, Inc. (NASDAQ: BLFS), a prominent player in the development and supply of cell processing tools and services for the cell and gene therapy market, has announced the sale of its biostorage subsidiary, SciSafe Holdings, Inc. The...

Continue Reading
Advancements in Universal Vaccine Development by Dx&Vx

Updated Category News Views 154

Innovative Pathway Towards a Universal COVID-19 Vaccine In the wake of a global resurgence of COVID-19, Dx&Vx (DXVX) is stepping up its efforts to develop a universal vaccine aimed at providing protection against all variants of the virus. With the recent acquisition of cutting-edge technology, this next-generation vaccine is set to attract significant global interest....

Continue Reading